Приказ основних података о документу

dc.creatorEkiz, Elif
dc.creatorOz, Emel
dc.creatorAbd El-Aty, A.M.
dc.creatorProestos, Charalampos
dc.creatorBrennan, Charles
dc.creatorZeng, Maomao
dc.creatorTomasevic, Igor
dc.creatorElobeid, Tahra
dc.creatorÇadırcı, Kenan
dc.creatorBayrak, Muharrem
dc.creatorOz, Fatih
dc.date.accessioned2023-05-05T07:09:51Z
dc.date.available2023-05-05T07:09:51Z
dc.date.issued2023
dc.identifier.issn2304-8158
dc.identifier.urihttp://aspace.agrif.bg.ac.rs/handle/123456789/6331
dc.description.abstractGanoderma lucidum is a medicinal mushroom that has been traditionally used in Chinese medicine for centuries. It has been found to have a wide range of medicinal properties, including antioxidant, anti-inflammatory, and immune-boosting effects. Recent research has focused on the potential benefits of G. lucidum in treating metabolic disorders such as diabetes and obesity, as well as its possible role in preventing and treating infections caused by the coronavirus. Triterpenoids are a major group of bioactive compounds found in G. lucidum, and they have a range of biological activities, including anti-inflammatory and antioxidant properties. These compounds have been found to improve insulin sensitivity and lower blood sugar levels in animal models of diabetes. Additionally, G. lucidum polysaccharides have been found to reduce bodyweight and improve glucose metabolism in animal models of obesity. These polysaccharides can also help to increase the activity of certain white blood cells, which play a critical role in the body’s immune response. For coronavirus, some in vitro studies have shown that G. lucidum polysaccharides and triterpenoids have the potential to inhibit coronavirus infection; however, these results have not been validated through clinical trials. Therefore, it would be premature to draw any definitive conclusions about the effectiveness of G. lucidum in preventing or treating coronavirus infections in humans. © 2023 by the authors.
dc.languageEnglish
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceFoods
dc.sourceFoods
dc.subjectanticancer
dc.subjectantidiabetic
dc.subjectantioxidant
dc.subjectbioactive compounds
dc.subjectcardiovascular diseases
dc.subjectCOVID-19
dc.subjectGanoderma lucidum
dc.titleExploring the Potential Medicinal Benefits of Ganoderma lucidum: From Metabolic Disorders to Coronavirus Infections
dc.typearticleen
dc.rights.licenseBY
dc.citation.issue7
dc.citation.rankM24
dc.citation.volume12
dc.identifier.doi10.3390/foods12071512
dc.identifier.fulltexthttp://aspace.agrif.bg.ac.rs/bitstream/id/24533/Exploring_the_Potential_PUB_2023.pdf
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу